CONCERT is excited to announce this year’s Early Career Researcher (ECR) Grant recipients: Dr Kara Vine-Perrow from the Targeted Cancer Research Laboratory at the Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong and Dr Gabriel Gabriel from University of New South Wales (UNSW).
Dr Vine-Perrow and her team will investigate localised immunotherapy for pancreatic cancer. The project involves the use of a novel drug delivery strategy which enables the administration of a combination of agents directly to a pancreatic tumour. This approach switches the immune system back on, increasing the accumulation and effectiveness of immunotherapy within the lesion and reduces off-target effects.
Dr Gabriel Gabriel’s project will investigate the disparity between cancer survival rates of Aboriginal and Torres Strait Islanders and that of non-Aboriginal Australians. The factors which contribute to poorer survival rates in Aboriginal and Torres Strait Islanders include more advanced disease at diagnosis, higher rates and comorbidity and less access to medical services. This study will be the first of its kind in NSW and will inform recommendations to improve cancer outcomes for Aboriginal people.
CONCERT congratulates this year’s recipients.
Keep an eye out on for future updates on these two projects.